| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/01/2005 | US20050191678 Using polymorphic variation in adrenergic receptor as tool in diagnosing/prognosing genetic disorders |
| 09/01/2005 | US20050191676 Kit comprising packaged probes for identifying preferential nucleotide sequences |
| 09/01/2005 | US20050191675 Methods of using an array of pooled probes in genetic analysis |
| 09/01/2005 | US20050191674 Using genomic fragile sites as diagnostic tools in detection of cell proliferative disorders |
| 09/01/2005 | US20050191672 Nucleotide sequences for use in controlling expression of serine/threonine kinase and treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular and skin disorders |
| 09/01/2005 | US20050191669 Using polymorphisms in checkpoint kinase 2 (CHK2), cyclin-dependent kinase inhibitor (CDKN2A) and caspase recruitment domain genes as diagnostic and prognostic tool in predicting cell proliferative disorders; immunodiagnostics |
| 09/01/2005 | US20050191668 Methods of using peroxisome proliferator-activated receptor alpha target genes |
| 09/01/2005 | US20050191667 Using mutant mannose-binding lectin gene as diagnostic indicator of vaginal urogenital disorders |
| 09/01/2005 | US20050191666 Method of identification and cloning differentially expressed messenger RNAs |
| 09/01/2005 | US20050191663 Microfabricated flowthrough porous apparatus for discrete detection binding reactions |
| 09/01/2005 | US20050191662 Peptide nucleic acid fusion for use in cell-free translation systems |
| 09/01/2005 | US20050191659 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 09/01/2005 | US20050191657 Such as 2-pyrrolidinone; an N-alkyl-pyrrolidinone; delta-valerolactam; and epsilon-caprolactam; kits |
| 09/01/2005 | US20050191656 Enhanced sequencing by hybridization using pools of probes |
| 09/01/2005 | US20050191655 Microarray composed of nucleotide sequences comprising modified backbone for use in identification of new genes, determination of transcriptional levels and diagnosis of disease |
| 09/01/2005 | US20050191654 Compositions and methods for diagnosing and treating chronic lymphocytic leukemia |
| 09/01/2005 | US20050191653 Oligonucleotide for use in controlling expression of sodium-dependent glucose cotransporters (SGLT2) gene sequenes and treatment of diabetes |
| 09/01/2005 | US20050191652 Using polymorphic mutation in fibroblast growth factor gene as diagnosis/prognosis of nervous system disorders |
| 09/01/2005 | US20050191651 Temperature-jump enhanced electrochemical detection of nucleic acid hybridization |
| 09/01/2005 | US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders |
| 09/01/2005 | US20050191648 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 09/01/2005 | US20050191646 Nucleic acid analysis techniques |
| 09/01/2005 | US20050191643 Cyanine compounds and their application as quenching compounds |
| 09/01/2005 | US20050191642 Labeling individual mammalian chromosomes in mitotic cells by in situ hybridization with chromosome-specific probes; classification of chromosomal aberrations |
| 09/01/2005 | US20050191640 Using presence hypermethylated promoter in tumor suppressor gene (HIN-1) as diagnostic tool in detection of cell proliferative disorders |
| 09/01/2005 | US20050191639 Method to isolate genes involved in aging |
| 09/01/2005 | US20050191637 Using amplification of expressed sequence tags as non-invasive method for diagnosis, prognosis and monitoring of genetic and infectious disease in humans and animals |
| 09/01/2005 | US20050191636 Using presence of short tandem repeat polymorphism (STRP) in CGG sequence as diagnostic tool in screening for mental developmental disorders |
| 09/01/2005 | US20050191634 Nucleotide sequences isolated via suppression subtractive hybridization for use as tool in detection of cell proliferative disorders |
| 09/01/2005 | US20050191633 Isolated from Bacillus substilus; immunogens; solid phase synthesis; reverse transcription; kits |
| 09/01/2005 | US20050191632 Cytogenetic abnormalities that are predictive of response to therapy for chronic lymphocytic leukemia |
| 09/01/2005 | US20050191631 Screening compounds for centromere-associated protein E (CENP-E) activity by determining plus end-directed microtubule motor activity, ATPase activity, or microtubule binding activity of a candidate compound, especially on Xenopus CENP-E |
| 09/01/2005 | US20050191629 Polymer extraction methods |
| 09/01/2005 | US20050191627 Enzymes |
| 09/01/2005 | US20050191625 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 09/01/2005 | US20050191622 Classifying human red blood cell (RBC) types; blood screening and transfusion |
| 09/01/2005 | US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 09/01/2005 | US20050191620 Particle on membrane assay system |
| 09/01/2005 | US20050191618 chemically synthesized double stranded siNA against HIV-1 or HIV-2 RNA; treatment of HIV infection or AIDS |
| 09/01/2005 | US20050191616 Membrane and 1,2-dipalmitoyl-sn-glycero-3-phospho-N-(2-hydroxymethyl)-3,5-divinylbenzamide; DNA sequencing |
| 09/01/2005 | US20050191615 Method for analysis of cell structure, and cell structure |
| 09/01/2005 | US20050191614 High speed drug screening; (near) infrared spectrometry, nuclear magnetic resonance, X-ray diffractometry, neutron diffractometry, light/electron microscopy, harmonic generation, circular/linear dichroism spectrometry, differential scanning calorimetry, Raman spectrometry |
| 09/01/2005 | US20050191613 Device for monitoring cells |
| 09/01/2005 | US20050191316 Neisseria genomic sequences and methods of their use |
| 09/01/2005 | US20050191306 Cancerous disease modifying antibodies |
| 09/01/2005 | US20050191305 Cancerous disease modifying antibodies |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191297 Sampling from biopsy of transplanted graft; administering a CD20 antagonist such as rituximab, humanized 2H7, or antibody conjugated to cytotoxic agent |
| 09/01/2005 | US20050191272 Methods for producing Ex vivo models for inflammatory disease and uses thereof |
| 09/01/2005 | US20050189240 Method and chemical sensor for determining concentrations of hydrogen peroxide and its precusor in a solution |
| 09/01/2005 | DE19758598B4 Verfahren zur Prüfung von Materialien hinsichtlich ihrer potentiellen antimikrobiellen Wirksamkeit und der Proliferation von Zellen auf ihrer Oberfläche Procedures for testing of materials in terms of their potential antimicrobial activity and proliferation of cells on its surface |
| 09/01/2005 | DE102004038076A1 Use of annexin A3, or other proteins, as diagnostic markers for cancer, especially of the prostate, also use of modulators of these markers for treating cancer |
| 09/01/2005 | CA2567042A1 Enrichment methods for the detection of pathogens and other microbes |
| 09/01/2005 | CA2559952A1 Instrument, method and kit for detecting lactobacillus brevis and lactobacillus lindneri |
| 09/01/2005 | CA2558685A1 Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle |
| 09/01/2005 | CA2558682A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders |
| 09/01/2005 | CA2558680A1 2031 oxidoreductase |
| 09/01/2005 | CA2558366A1 Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling |
| 09/01/2005 | CA2557177A1 Methods and kits for analyzing polynucleotide sequences |
| 09/01/2005 | CA2556913A1 Solid-fluid composition and uses thereof |
| 09/01/2005 | CA2556868A1 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation |
| 09/01/2005 | CA2556861A1 Protein ligands for nkg2d and ul16 receptors and uses thereof |
| 09/01/2005 | CA2556418A1 Methods and materials using signaling probes |
| 09/01/2005 | CA2556190A1 Identification of soybeans having resistance to phytophthora sojae |
| 09/01/2005 | CA2556186A1 Methods for coupling tomato yello leaf curl virus and root knot nematode resistance alleles in tomato |
| 09/01/2005 | CA2556178A1 Methods and compositions for inferring eye color and hair color |
| 09/01/2005 | CA2556177A1 Genetic predictability for acquiring a disease or condition |
| 09/01/2005 | CA2556172A1 Selective growth medium for listeria spp |
| 09/01/2005 | CA2556141A1 Method and device for detecting feline immunodeficiency virus |
| 09/01/2005 | CA2556098A1 Wound healing composition |
| 09/01/2005 | CA2555989A1 Method for determining the risk of developing a neurological disease |
| 09/01/2005 | CA2555972A1 Hyphal growth in fungi |
| 09/01/2005 | CA2555737A1 Schizochytrium fatty acid synthase (fas) and products and methods related thereto |
| 09/01/2005 | CA2555542A1 P53 wild-type as biomarker for the treatment with mtor inhibitors in combination with a cytotoxic agent |
| 09/01/2005 | CA2555377A1 Genetic analysis by sequence-specific sorting |
| 09/01/2005 | CA2555233A1 Wound healing profile |
| 09/01/2005 | CA2555208A1 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof |
| 09/01/2005 | CA2554477A1 High throughput screening methods for lubricating oil compositions |
| 09/01/2005 | CA2541189A1 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in prokaryotes |
| 09/01/2005 | CA2539436A1 Using liquid crystals to detect affinity microcontact printed biomolecules |
| 08/31/2005 | EP1569156A2 Method of selecting optimized SNP marker sets from multiple SNP markers associated with a complex disease |
| 08/31/2005 | EP1569155A1 Method of detecting an error spot in a DNA chip and system using the method |
| 08/31/2005 | EP1568997A2 Surface for detection of interaction between substances and corresponding sensor chip, sensing device and detection method |
| 08/31/2005 | EP1568994A1 Method of analyzing coenzyme q-10 and two-electron reduction product thereof and analysis system |
| 08/31/2005 | EP1568993A1 Sensitivity enhanced biomolecule field effect transistor |
| 08/31/2005 | EP1568787A1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1 |
| 08/31/2005 | EP1568786A2 Analysis of methylation status using nucleic acid arrays |
| 08/31/2005 | EP1568785A2 Method for detecting oligonucleotides and determining base sequence of nucleic acids |
| 08/31/2005 | EP1568784A2 Method for monitoring the effect of compounds on Foxc2 expression |
| 08/31/2005 | EP1568783A2 A novel nucleic acid based steganography system and application thereof |
| 08/31/2005 | EP1568782A1 Diagnosis and therapy of ADAMTS-13 associated diseases |
| 08/31/2005 | EP1568779A1 HSV strains for the oncolytic treatment of cancer |
| 08/31/2005 | EP1568775A1 Cancer-associated gene |
| 08/31/2005 | EP1568767A2 Dna fragments of lav genes |
| 08/31/2005 | EP1568766A1 Device for pretreating specimen |
| 08/31/2005 | EP1568376A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 08/31/2005 | EP1567866A1 Apparatuses and methods for assaying analytes using photoelectrochemical labels |
| 08/31/2005 | EP1567864A2 Composition for treating chlamydia infections and method for identifying same |
| 08/31/2005 | EP1567861A1 Centrifugal device and method for performing binding assays |
| 08/31/2005 | EP1567860A2 Methods and materials for examining pathways associated with glioblastoma progression |